Solid Biosciences
SLDB
SLDB
82 hedge funds and large institutions have $132M invested in Solid Biosciences in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
73% less call options, than puts
Call options by funds: $47K | Put options by funds: $176K
Holders
82
Holding in Top 10
–
Calls
$47K
Puts
$176K
Top Buyers
| 1 | +$3.05M | |
| 2 | +$948K | |
| 3 | +$548K | |
| 4 |
Morgan Stanley
New York
|
+$472K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$470K |
Top Sellers
| 1 | -$9.77M | |
| 2 | -$975K | |
| 3 | -$776K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$401K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$368K |